SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model.

Human Gene Therapy
S P SinghVikas Kundra

Abstract

The most common cause of cancer-related deaths in North America is lung cancer, 85% of which is non-small cell lung cancer (NSCLC). Gene therapy is a promising approach, but has been hindered by lack of methods for localizing and quantifying gene expression in vivo. Human somatostatin receptor subtype-2 (SSTR2)-based reporters can be used to follow gene expression in vivo using ligands with greater affinity for this subtype. NSCLCs can express SSTR subtypes, which may interfere with SSTR2-based reporters. We assessed whether a SSTR2-based reporter can serve as a reporter of gene transfer into NSCLCs. SSTR subtype expression was assessed in NSCLC cell lines A549, H460, and H1299 using RT-PCR. After infection with an adenovirus containing hemagglutinin-A-tagged-SSTR2 (Ad-HA-SSTR2) or control insert, expression was assessed by immunologic techniques and binding to clinically-approved (111)In-octreotide. In vivo, after magnetic resonance (MR) imaging, intrathoracic H460 tumors were injected with Ad-HA-SSTR2 or control virus (n = 6 mice/group) under ultrasound guidance. Intravenous injection of (111)In-octreotide 2 days later was followed by planar and single-photon emission computed tomography (SPECT) imaging. Biodistribution into ...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F W KluxenH Lübbert
Feb 15, 1990·International Journal of Cancer. Journal International Du Cancer·J C ReubiV Macaulay
Aug 1, 1995·The Annals of Thoracic Surgery·J C NesbittC F Mountain
Jan 1, 1993·Trends in Neurosciences·G I Bell, T Reisine
Oct 1, 1994·European Journal of Nuclear Medicine·D J KwekkeboomE P Krenning
Dec 1, 1994·European Journal of Nuclear Medicine·C M KirschK Tatsch
Jun 1, 1993·Mayo Clinic Proceedings·J R Jett
May 1, 1997·Gene Therapy·R de MartinB R Binder
Jan 14, 2000·Clinical Nuclear Medicine·S K LauM N Coel
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·J G TjuvajevR G Blasberg
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·A HemminkiR D Alvarez
Nov 13, 2001·Gene Therapy·X SunS S Gambhir
Jul 4, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Qianwa LiangHarvey R Herschman
Sep 1, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·J Andrea McCartDavid L Bartlett
Mar 30, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Antonia Dimitrakopoulou-StraussLudwig G Strauss
Sep 22, 2006·Clinical Medicine & Research·Deanna Cross, James K Burmester
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Rachel BenamoreStephen Herman
Oct 11, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giorgio Scagliotti
Dec 7, 2007·Journal of Magnetic Resonance Imaging : JMRI·James A BanksonVikas Kundra
May 12, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association

❮ Previous
Next ❯

Citations

Jun 4, 2014·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Geok Choo SimLaszlo Radvanyi
Jun 4, 2011·Expert Opinion on Biological Therapy·Peggy Richard-FiardoBéatrice Cambien
Apr 17, 2015·BioMed Research International·Caiyun Xu, Hong Zhang
Aug 3, 2013·Cold Spring Harbor Protocols·Scott K LyonsKevin M Brindle
Nov 21, 2015·The Cancer Journal·Laszlo G Radvanyi
May 14, 2021·Molecular Therapy Oncolytics·Susanna C ConcilioKah-Whye Peng

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis
ELISA

Software Mentioned

Excel
Image J

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.